EMAIL THIS PAGE TO A FRIEND

Cancer letters

Four types of fatty acids exert differential impact on pancreatic cancer growth.


PMID 25676690

Abstract

Increased fatty acids (FAs) regulate pancreatic cancer progression, however, the detailed mechanism is not clear, and different forms of FAs may play diversified roles in pancreatic cancer. To elucidate the underlying mechanism, we compared the effects of four major types of FAs on pancreatic cancer growth both in cell culture and in a mouse model. HPAF pancreatic cancer cells were implanted in nude mice for 14 weeks, and the mice were fed with four different high-fat/high-energy diets (15% fat, 4 kcal/g), an iso-caloric diet (5% fat, 4 kcal/g) and a normal diet (4% fat, 3 kcal/g). The high fat diets were rich in saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-6 and n-3 polyunsaturated fatty acids (n6- and n3PUFAs), respectively. While n3PUFA diet decreased tumor viability, the other high fat diets stimulated tumor viability by apparently different mechanisms. For instance, xenografts whose carriers were fed with SFA diet had marked expression of cancer-related proteins and lipid droplets. Although mice that were fed with MUFA- and n6PUFA diets had pancreatic tumors of similar size, liver metastasis occurred more frequently in those with the n6PUFA diet. In experiments in vitro, the HPAF-cell population was increased by SFAs and MUFAs, decreased by n3PUFAs and not changed by n6PUFAs. In conclusion, different fatty acids have different impact on pancreatic cancer cells. The effects of fatty acids on pancreatic cancer cells were consistent in vivo and in vitro except that n6PUFAs only had regulatory effects in vivo.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

261556
(L)-Dehydroascorbic acid
C6H6O6
A9673
Arachidonic acid, from porcine liver, ≥99% (GC), liquid
C20H32O2
A3555
Arachidonic acid, from porcine liver, BioReagent, suitable for cell culture, ≥99% (GC)
C20H32O2
A3925
Arachidonic acid, from porcine liver, ≥85% (capillary GC), liquid
C20H32O2
10931
Arachidonic acid, >95.0% (GC)
C20H32O2
A3611
Arachidonic acid, from non-animal source, ≥98.5% (GC)
C20H32O2
D8132
Dehydro-L-(+)-ascorbic acid dimer, ≥80% (enzymatic)
C12H12O12
L556
Dodecanoic acid, 98%
C12H24O2
L4250
Dodecanoic acid, ≥99% (GC/titration)
C12H24O2
61609
Dodecanoic acid, analytical standard
C12H24O2
61620
Dodecanoic acid, purum, ≥96.0% (GC)
C12H24O2
W261408
Lauric acid, ≥98%, FCC, FG
C12H24O2
W261416
Lauric acid, natural, ≥98%, FCC, FG
C12H24O2
Y0001474
Lauric acid, European Pharmacopoeia (EP) Reference Standard
C12H24O2
L1376
Linoleic acid, ≥99%
C18H32O2
L1012
Linoleic acid, liquid, BioReagent, suitable for cell culture
C18H32O2
L1268
Linoleic acid, ≥93% (GC)
C18H32O2
62230
Linoleic acid, analytical standard
C18H32O2
W338001
Linoleic acid, ≥95%
C18H32O2
62240
Linoleic acid, technical, 60-74% (GC)
C18H32O2
L2376
Linolenic acid, ≥99%
C18H30O2
62170
Linolenic acid, ~70% (GC)
C18H30O2
62160
Linolenic acid, analytical standard
C18H30O2
75090
Oleic acid, analytical standard
C18H34O2
Y0001479
Oleic acid, European Pharmacopoeia (EP) Reference Standard
C18H34O2
05508
Oleic acid, Selectophore, ≥99.0%
C18H34O2
P5585
Palmitic acid, BioXtra, ≥99%
C16H32O2
P0500
Palmitic acid, ≥99%
C16H32O2
P0625
Palmitic acid, Grade II, ~95%
C16H32O2
43051
Palmitic acid, certified reference material, TraceCERT®
C16H32O2